Dr Reddy’s Laboratories’s (DRL)US subsidiary faces allegations for drug overpricing

  • 0
  • 6 Feb, 2019 10:37 am

Hyderabad: US-based insurance company, files complaint to US Securities and Exchange Commission (SEC) against Dr. Reddy’s Laboratories US based subsidiary for drug overpricing. The company strongly apposed the allegations and denied of any wrongdoing. Besides, on September 25, 2018, Marion Diagnostic Center LLC and Marion Healthcare LLC too filed a complaint against Dr Reddy’s Laboratories. It was specifically named with respect to two drugs Meprobamate and Zoledronic Acid. 


Leave a Reply